 |
Patents available for license
The following patents, patent applications and their equivalents are available for license. Please send all questions and enquiries to oligomedicines@aveciabiotech.com or call +1 (508) 482 7500.
WO 04/035599 (SMC 60554) |
The use of saccharin-n-methyl imidazole for the preparation of nucleoside phosphoramidites |
WO 03/004512 (SMC 60479) |
Saccharin-n-methyl imidazole and analogs as activators for phosphoramidite chemistry |
WO 03/080834 (SMC 60475) |
Titratable anion exchange resins for the purification of synthetic oligonucleotides |
WO 02/088160 (SMC 60474) |
Immobilisation of oligonucleotides onto solid supports |
US 6,538,128 (SMC 41026) |
Novel detritylation solvents for oligonucleotide synthesis |
US 6,500,944 (SMC 41025) |
Novel sulfurising agents (3-aryl-1,2,4-dithiazoline-5-ones) |
US 6,096,881 (SMC 41024) |
Sulfur transfer reagents for oligonucleotide synthesis (xanthane hydride and analogs) |
US 5,739,314 (SMC 41023) |
Method for synthesizing 2’-O-substituted pyrimidine nucleosides |
US 6,384,209 (SMC 41022) |
Novel sulfur transfer agents for oligonucleotide synthesis |
WO 01/96358 (SMC 60430) |
Method for preventing the modification of synthetic oligonucleotides during removal of protecting groups |
US 6,087,491; US 6,310,198
(SMC 41007) |
Extremely high purity oligonucleotides and methods of synthesizing them using dimer blocks |
WO 04/055037 (SMC 60566) |
Purification of oligonucleotide synthons using nanofiltration |
WO 04/055030 (SMC 60562) |
A process for the preparation of phosphitylating agents, particularly tetraphos |
WO 02/46205 (SMC 60455) |
A method for the synthesis of oligonucleotides |
WO 01/64702 (SMC 60412) |
A method for the synthesis of oligonucleotides using H-phosphonate chemistry in a 4-component system |
US 6,506,894
(SMC 41004) |
A method for synthesising oligonucleotides in solution using H-phosphonate coupling and in-situ sulfur transfer |
US 5,681,945 ; US 5,886,193
(SMC 36847) |
Universal support for DNA or RNA synthesis |
US 5,552,539 |
The use of TEA .3HF for the de-blocking of TBDMS protected hydroxyl groups in RNA synthesis |
|
|
